← Leaderboards
Annelise Poss
University Of Utah
$121,876
Attributed
$121,876
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $73.4K · FY2021–24$100K$75K$50K$25K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$121,876 · 2
By mechanism
F32$73,408 · 1
F31$48,468 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- William L Holland$8,337,489
- Mary Christine Playdon$2,092,255
- Laurie K Jackson$1,218,421
- John David Symons$3,553,170
- John Dearborn Phillips$6,351,975
Others in their field
Other Emerging Leaders on “Prevent”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$141,293,697
- Kimberly Smith · Ppd Development Lp$115,671,664
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$112,282,390
- Beth Baseler · Leidos Biomedical Research, Inc.$100,071,064
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
Research focus
PreventAblationMetabolismProductionLipidsEnzymesHepaticMetabolicPathogenesisTrainingMouse ModelMitochondriaHepatocyteDisease ProgressionApoptosisEffective TherapyDihydroceramideAdultDihydroceramide DesaturaseEndoplasmic Reticulum StressComplexBaseCell TypeCoupled
Grant awards (3)
Mitochondrial succinyl CoA management at the intersection of heme and ketone metabolism$73,408
F32 · FY2024 · HL · contact PI
Ceramides as Lipotoxic Mediators of Non-Alcoholic Fatty Liver Diseases and Non-Alcoholic Steatohepatitis$12,512
F31 · FY2022 · DK · contact PI
Ceramides as Lipotoxic Mediators of Non-Alcoholic Fatty Liver Diseases and Non-Alcoholic Steatohepatitis$35,956
F31 · FY2021 · DK · contact PI